{"protocolSection":{"identificationModule":{"nctId":"NCT03698149","orgStudyIdInfo":{"id":"17-23028"},"secondaryIdInfos":[{"id":"U01DC018671","type":"NIH","link":"https://reporter.nih.gov/quickSearch/U01DC018671"}],"organization":{"fullName":"University of California, San Francisco","class":"OTHER"},"briefTitle":"ECoG BMI for Motor and Speech Control","officialTitle":"A High-Performance ECoG-based Neural Interface for Communication and Neuroprosthetic Control","acronym":"BRAVO"},"statusModule":{"statusVerifiedDate":"2022-07","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2018-11-09","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-08-15","type":"ESTIMATED"},"completionDateStruct":{"date":"2030-08-15","type":"ESTIMATED"},"studyFirstSubmitDate":"2018-08-21","studyFirstSubmitQcDate":"2018-10-03","studyFirstPostDateStruct":{"date":"2018-10-05","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-07-29","lastUpdatePostDateStruct":{"date":"2022-08-02","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Karunesh Ganguly","investigatorTitle":"Associate Professor","investigatorAffiliation":"University of California, San Francisco"},"leadSponsor":{"name":"University of California, San Francisco","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true},"descriptionModule":{"briefSummary":"Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.","detailedDescription":"ECoG is a type of electrophysiological monitoring that uses electrodes placed directly on the exposed surface of the brain to record electrical activity. With this ECoG-based neural interface, study patients will undergo training and assessment of their ability to control a complex robotic system and to determine if ECoG brain signals can be used to produce speech."},"conditionsModule":{"conditions":["ALS","SCI - Spinal Cord Injury","Stroke","Multiple Sclerosis","Muscular Dystrophies"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["EARLY_PHASE1"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"DEVICE_FEASIBILITY","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":3,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Electrocorticography-based brain computer interface","type":"EXPERIMENTAL","interventionNames":["Device: PMT/Blackrock Combination Device"]}],"interventions":[{"type":"DEVICE","name":"PMT/Blackrock Combination Device","description":"PMT Subdural Cortical Electrodes/Blackrock NeuroPort Array and NeuroPort System","armGroupLabels":["Electrocorticography-based brain computer interface"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]","description":"The primary endpoint of this study is to determine the incidence of treatment-emergent adverse events associated with the ECoG-based interface","timeFrame":"Up to 6 years post-implant period"},{"measure":"NIDCD Primary Objective 1","description":"To enable communication via text decoded from neural signals.","timeFrame":"Up to 6 years post-implant period"},{"measure":"NIDCD Primary Objective 2","description":"To enable communication via synthesized speech decoded from neural signals.","timeFrame":"Up to 6 years post-implant period"}],"secondaryOutcomes":[{"measure":"NIDCD Secondary Objective 1","description":"To evaluate communication via text decoded from neural signals.","timeFrame":"Up to 6 years post-implant period"},{"measure":"NIDCD Secondary Objective 2","description":"To evaluate communication via synthesized speech decoded from neural signals.","timeFrame":"Up to 6 years post-implant period"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Age \\> 21\n2. Limited ability to use upper limbs, based on neurological examination, due to stroke, amyotrophic lateral sclerosis (ALS), multiple sclerosis, cervical spinal cord injury, brainstem stroke, muscular dystrophy, myopathy or severe neuropathy.\n3. Disability, defined by a 4 or greater score on the Modified Rankin Scale, must be severe enough to cause loss of independence and inability to perform activities of daily living.\n4. If stroke or spinal cord injury, at least 1 year has passed since onset of symptoms\n5. Must live within a two-hour drive of UCSF\n\nExclusion Criteria:\n\n1. Pregnancy or breastfeeding\n2. Inability to understand and/or read English\n3. Inability to give consent\n4. Dementia, based on history, physical exam, and MMSE\n5. Active depression (BDI \\> 20) or other psychiatric illness (active general anxiety disorder, schizophrenia, bipolar disorder, obsessive-compulsive disorder (OCD), or personality disorders (e.g. multiple personality disorder, borderline personality disorder, etc.)\n6. History of suicide attempt or suicidal ideation\n7. History of substance abuse\n8. Co-morbidities including ongoing anticoagulation, uncontrolled hypertension, cancer, or major organ system failure\n9. Inability to comply with study follow-up visits\n10. Any prior intracranial surgery\n11. History of seizures\n12. Immunocompromised\n13. Has an active infection\n14. Has a CSF drainage system or an active CSF leak\n15. Requires diathermy, electroconvulsive therapy (ECT), or transcranial magnetic stimulation (TMS) to treat a chronic condition\n16. Has an implanted electronic device such as a neurostimulator, cardiac pacemaker/defibrillator or medication pump, or presence of any head or neck metallic foreign bodies\n17. Allergies or known hypersensitivity to materials in the Blackrock NeuroPort Array (i.e. silicone, titanium) or the PMT Subdural Cortical Electrode (silicone, platinum iridium, nichrome)","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Adelyn Tu-Chan","role":"CONTACT","phone":"(415) 575-0431","email":"adelyn.tu@ucsf.edu"}],"overallOfficials":[{"name":"Karunesh Ganguly, MD, PhD","affiliation":"University of California, San Francisco","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"University of California San Francisco","status":"RECRUITING","city":"San Francisco","state":"California","zip":"94158","country":"United States","contacts":[{"name":"Adelyn Tu-Chan","role":"CONTACT","phone":"415-575-0431","email":"adelyn.tu@ucsf.edu"}],"geoPoint":{"lat":37.77493,"lon":-122.41942}}]},"referencesModule":{"references":[{"pmid":"36347863","type":"DERIVED","citation":"Metzger SL, Liu JR, Moses DA, Dougherty ME, Seaton MP, Littlejohn KT, Chartier J, Anumanchipalli GK, Tu-Chan A, Ganguly K, Chang EF. Generalizable spelling using a speech neuroprosthesis in an individual with severe limb and vocal paralysis. Nat Commun. 2022 Nov 8;13(1):6510. doi: 10.1038/s41467-022-33611-3."},{"pmid":"34260835","type":"DERIVED","citation":"Moses DA, Metzger SL, Liu JR, Anumanchipalli GK, Makin JG, Sun PF, Chartier J, Dougherty ME, Liu PM, Abrams GM, Tu-Chan A, Ganguly K, Chang EF. Neuroprosthesis for Decoding Speech in a Paralyzed Person with Anarthria. N Engl J Med. 2021 Jul 15;385(3):217-227. doi: 10.1056/NEJMoa2027540."}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000009136","term":"Muscular Dystrophies"},{"id":"D000009103","term":"Multiple Sclerosis"},{"id":"D000013119","term":"Spinal Cord Injuries"}],"ancestors":[{"id":"D000020278","term":"Demyelinating Autoimmune Diseases, CNS"},{"id":"D000020274","term":"Autoimmune Diseases of the Nervous System"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000003711","term":"Demyelinating Diseases"},{"id":"D000001327","term":"Autoimmune Diseases"},{"id":"D000007154","term":"Immune System Diseases"},{"id":"D000013118","term":"Spinal Cord Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000020196","term":"Trauma, Nervous System"},{"id":"D000014947","term":"Wounds and Injuries"},{"id":"D000020966","term":"Muscular Disorders, Atrophic"},{"id":"D000009135","term":"Muscular Diseases"},{"id":"D000009140","term":"Musculoskeletal Diseases"},{"id":"D000009468","term":"Neuromuscular Diseases"},{"id":"D000030342","term":"Genetic Diseases, Inborn"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M15606","name":"Spinal Cord Injuries","asFound":"Spinal Cord Injury","relevance":"HIGH"},{"id":"M11750","name":"Multiple Sclerosis","asFound":"Multiple Sclerosis","relevance":"HIGH"},{"id":"M15105","name":"Sclerosis","relevance":"LOW"},{"id":"M11783","name":"Muscular Dystrophies","asFound":"Muscular Dystrophy","relevance":"HIGH"},{"id":"M4319","name":"Autoimmune Diseases","relevance":"LOW"},{"id":"M21788","name":"Demyelinating Autoimmune Diseases, CNS","relevance":"LOW"},{"id":"M21784","name":"Autoimmune Diseases of the Nervous System","relevance":"LOW"},{"id":"M6599","name":"Demyelinating Diseases","relevance":"LOW"},{"id":"M9890","name":"Immune System Diseases","relevance":"LOW"},{"id":"M15605","name":"Spinal Cord Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17375","name":"Wounds and Injuries","relevance":"LOW"},{"id":"M21713","name":"Trauma, Nervous System","relevance":"LOW"},{"id":"M4279","name":"Atrophy","relevance":"LOW"},{"id":"M22387","name":"Muscular Disorders, Atrophic","relevance":"LOW"},{"id":"M11782","name":"Muscular Diseases","relevance":"LOW"},{"id":"M11787","name":"Musculoskeletal Diseases","relevance":"LOW"},{"id":"M12101","name":"Neuromuscular Diseases","relevance":"LOW"},{"id":"M23376","name":"Genetic Diseases, Inborn","relevance":"LOW"},{"id":"T3963","name":"Muscular Dystrophy","asFound":"Muscular Dystrophy","relevance":"HIGH"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC26","name":"Wounds and Injuries"},{"abbrev":"BC20","name":"Immune System Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}